| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 447 | 138 | 6 | 18 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 447 | 138 | 6 | 18 | | | Operating Expenses | | Research Development | 2,267 | 1,565 | 1,675 | 1,193 | | Selling General and Administrative | 1,463 | 1,500 | 1,277 | 1,197 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,283) | (2,927) | (2,946) | (2,372) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 12 | 26 | 68 | | Earnings Before Interest And Taxes | (3,278) | (2,915) | (2,920) | (2,304) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (3,278) | (2,915) | (2,920) | (2,304) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,278) | (2,915) | (2,920) | (2,304) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,278) | (2,915) | (2,920) | (2,304) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,278) | ($2,915) | ($2,920) | ($2,304) |
|
0.51% Nasdaq 
Income Statement
